Table 1 Cases of aromatase inhibitor induced radiation recall dermatitis (RRD).
Author (Year) | Age/Gender | Radiotherapy Dose (Gy) | Drug/Dose | Time | Treatment | RRD on Rechallenge | |
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Radiation to RRD | Drug to RRD | Â | Â |
Haydaroglu et al. (2012) | 68/F | 50 + 10 Gy | Anastrazole/1 mg | 2 mo | 2 mo | Methylprednisolone aseponate, 10% urea, and fusidic acid creams started; anastrozole discontinued | NA |
Foster et al. (2014) | 74/F | 50.4 + 10 Gy | Letrozole/2.5 mg | 2 mo | 30 days | Letrozole withdrawn | No |
aIoannidis et al. (2014) | 58/F | Data not available | Everolimus + Exemestane/10 mg + 25 mg | 10 yrs | 3 days | Exemestane + everolimus withdrawn; systemic corticosteroids, topical dexpanthenol started | No |
aMarchand et al. (2016) | 74/F | 66 Gy | Exemestane/25 mg | <1 yr | 27 days | Exemestane discontinued | NA |
Present case | 78/F | 42.56 + 8.1 Gy | Letrozole/2.5 mg | 9 yrs | 14 days | Letrozole discontinued | NA |
